TY  - JOUR
T1  - Insulin-like growth factor-1 enhances mortality risk in women with breast cancer through epithelial-mesenchymal transition initiation
A1  - Ala-Eddin Moustafa
JF  - Clinical Cancer Investigation Journal
JO  - Clin Cancer Investig J
SN  - 2278-0513
Y1  - 2013
VL  - 2
IS  - 3
SP  - 175
EP  - 177
N2  - The metastatic disease which leads to cancer patients′ mortality results from a multi-step process of tumor progression caused by gene alteration and cooperation. Accordingly, it was recently demonstrated that alteration level of insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) are associated with the risk of cancer related death in several human malignancies including breast cancer. On the other hand, epithelial-mesenchymal transition (EMT) is described as a crucial event in cancer progression and metastasis. Herein, we discuss the association between IGF-1, IGF-1/IGFBP-3 ratio, EMT, and breast cancer mortality.
UR  - https://ccij-online.org/article/insulin-like-growth-factor-1-enhances-mortality-risk-in-women-with-breast-cancer-through-epithelial-mesenchymal-transition-initiation-110
ER  -